In conversation with WIRED
Professor Mark Kendall’s inventions have drawn attention from some of the world’s biggest names. Think the World Health Organization, the Bill & Melinda Gates Foundation and F1 Grand Prix winner Mark Webber.
The backing of a proven sporting degree
WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.
A critical conversation with Planet Hope
Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.
Trials attract national attention
In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.
Manufacturing project worth $3.9 million
We are very excited to share that WearOptimo has been awarded a $973,000 grant under the Australian Government’s Manufacturing Modernisation Fund (MMF) through the Department of Industry, Science, Energy and Resources.
$30 million manufacturing project
World-leading, lifesaving wearable medical technology will be produced at a new Queensland facility, supported by an up to $30 million project announced today.
WearOptimo’s strategic partnership agreement with Aspen Medical
A key milestone on our commercial journey was reached today with the announcement of a partnership between WearOptimo and Aspen Medical.
Professor Mark Kendall with Harvard Club of Australia
Can Australia become a world leader in personalised medicine? Professor Mark Kendall discusses with Harvard Club of Australia.
WearOptimo drives forward Microwearables with $2.5 million in funding
In a recent announcement from Acting Health Minister Hon. Alan Tudge MP, WearOptimo received the news that it is to receive $980,000 from the Australian Federal Government as part of the BioMedTech Horizons (BMTH) program.
Prof Mark Kendall invited to act as co-chair of government initiative supporting stem cell therapies
Professor Mark Kendall has been invited to act as co-chair of the Expert Advisory Panel of the Stem Cell Therapies Mission, helping world-class Australian researchers further investigate game-changing medical treatments for many chronic and inherited diseases.